Ambrosia Biosciences Revenue

Biotechnology Research • Boulder, CO, United States • 21-50 Employees

Ambrosia Biosciences revenue & valuation

Annual revenue	$2,908,870
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$9,400,000
Total funding	$53,500,000

Key Contacts at Ambrosia Biosciences

Kyle Lefkoff

Chairman Of The Board And Founder

Kieran Chacko

Co-Founder & Strategic Advisor

Dean Kahn

Associate Director - Medicinal Chemistry

Donald Backos

Director Of Computational Chemistry

Spencer Peck

Associate Director

Michael Ayres

Director Of Facilities

Karin Brown

Associate Director, Adme/Dmpk

Tc Mou

Director Of Structural Biology

Faraz Naqvi

Medical Director

Company overview

Headquarters	Boulder, CO, United States
Phone number	+13033515800
Website	ambrosiabiosciences.com
NAICS	541714
Keywords	Small Molecule Drug Discovery, Glp-1, Incretin Hormones, Class B Gpcrs
Founded	2024
Employees	21-50
Socials

Ambrosia Biosciences Email Formats

Ambrosia Biosciences uses 3 email formats. The most common is {first name} (e.g., john@ambrosiabiosciences.com), used 50% of the time.

Format	Example	Percentage
{first name}	john@ambrosiabiosciences.com	50%
{first name}.{last name}	john.doe@ambrosiabiosciences.com	33.3%
{first name}{last name}	johndoe@ambrosiabiosciences.com	16.7%

About Ambrosia Biosciences

Ambrosia Biosciences Inc. is a privately held drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Entry

Vice President

Employees by Department

Ambrosia Biosciences has 15 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Ambrosia Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2024-09-06	1	$12,500,000
2024-09-06	4	$16,000,000
2025-01-10	4	$25,000,000

Funding Insights

$53,500,000

Total funding amount

$25,000,000

Most recent funding amount

Number of funding rounds

Ambrosia Biosciences Tech Stack

Discover the technologies and tools that power Ambrosia Biosciences's digital infrastructure, from frameworks to analytics platforms.

Swiper

JavaScript libraries

Animate.css

UI frameworks

Elementor

Page builders

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

PHP

Programming languages

WordPress

Blogs

Bootstrap

UI frameworks

Frequently asked questions

Ambrosia Biosciences is located in Boulder, CO, US.

You can reach Ambrosia Biosciences at +13033515800.

Ambrosia Biosciences generates an estimated annual revenue of $2,908,870. This revenue figure reflects the company's market position and business performance in its industry.

Ambrosia Biosciences has an estimated valuation of $9,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Ambrosia Biosciences was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Ambrosia Biosciences has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Ambrosia Biosciences has raised a total of $53,500,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Ambrosia Biosciences

Kyle Lefkoff

Chairman Of The Board And Founder

Kieran Chacko

Co-Founder & Strategic Advisor

Dean Kahn

Associate Director - Medicinal Chemistry

Donald Backos

Director Of Computational Chemistry

Spencer Peck

Associate Director

Michael Ayres